November 04, 2020 Scanning the horizon for future Covid-19 treatments Outside of vaccines and antibodies, few experimental agents have made it into large, robust clinical trials.
September 05, 2018 Abivax seeks funds to follow another fork Encouraging early data in inflammatory bowel disease have given Abivax a second avenue to pursue with its lead HIV asset.